XML 27 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
8. Stock Options
12 Months Ended
Dec. 31, 2017
Notes  
8. Stock Options

8.   Stock Options

 

The Company has a Stock Option Incentive Plan (“SIP”) to authorize the granting of stock options up to 10 percent of the total number of issued and outstanding shares of common stock to employees, directors and consultants. Upon exercise of options, shares are issued from the available authorized shares of the Company.  Option awards are generally granted with an exercise price equal to the fair market value of the Company’s stock at the date of grant. 

 

In July 2016, the Company granted 2,525,000 stock options to directors, officers, employees and consultants of the Company and its affiliates to purchase common shares of the Company. The options are exercisable on or before July 20, 2021 at a price of $0.10 per share.  The fair value of the options was determined to be $175,199 using the Black Scholes model.   The options were fully vested upon grant and recognized as compensation in Management and Administrative expense during the year ended December 31, 2016.   

 

In March 2017, the Company granted 600,000 stock options to three directors of the Company. The options are exercisable on or before March 31, 2022 at a price of $0.10 for 200,000 shares, and at a price of $0.09 for the remaining 400,000 shares.  The fair value of the options was determined to be $53,557 using the Black Scholes model.  The options were fully vested upon grant and recognized as compensation expense during the year ended December 31, 2017.   

 

On July 19, 2017, Paul Beckman exercised stock options representing 275,000 shares of common stock for total consideration of $28,275 which was in the form of the balance due on his note and interest expense of $20,000 and $125, respectively, and $8,150 in cash.  Additionally, Larry Thackery exercised stock options for 140,000 shares of common stock for $12,400 in cash.   The intrinsic value these options was approximately $5,000.

 

The fair value of each option award was estimated on the date of the grant using the assumptions noted in the following table:

 

 

 

2017

 

2016

Number of Options

600,000

 

2,525,000

Stock price, minimum

$0.09

 

$0.10

Stock price, maximum

$0.10

 

-

Exercise price, minimum

$0.09

 

$0.10

Exercise price, maximum

$0.10

 

-

Expected volatility

235.5%

 

238.9%

Expected dividends

-

 

-

Expected terms (in years)

5.0

 

5.0

Risk-free rate

1.96%

 

1.15%

 

 

The following is a summary of the Company’s options issued under the Stock Option Incentive Plan:

 

 

 

Shares

 

Weighted Average Exercise Price

Outstanding and exercisable at December 31, 2015

3,990,000

 

0.17

Expired

(2,000,000)

 

(0.27)

Granted

2,525,000

 

0.10

Outstanding and exercisable at December 31, 2016

4,515,000

 

$ 0.08

Granted

600,000

 

0.09

Exercised

(415,000)

 

0.10

Outstanding and exercisable at December 31, 2017

4,700,000

 

$0.09

 

 

The average remaining contractual term of the options outstanding and exercisable at December 31, 2017 was 2.46 years.  As of December 31, 2017, options outstanding and exercisable had an aggregate intrinsic value of approximately $542,000 based on the Company’s stock price of $0.20.